Browsing Research publications by Title
Now showing items 15673-15692 of 22784
-
The phagocytic capacity of neurones
(2007-05)Phagocytosis is defined as the ingestion of particulates over 0.5 microm in diameter and is associated with cells of the immune system such as macrophages or monocytes. Neurones are not generally recognized to be phagocytic. ... -
Phaidon Archive of Graphic Design
(Phaidon Press, 2012)he Phaidon Archive of Graphic Design features 500 graphic designs including newspapers, magazines, posters, advertisements, typefaces, logos, corporate design, record covers and moving graphics from around the world, which ... -
Pharmaceutical foams : are they the answer to the dilemma of topical nanoparticles?
(2010)Nanoparticulate systems have the potential to improve topical drug delivery because of their capacity to enhance drug loading and dissolution, protect chemically unstable therapeutic agents, and improve product aesthetics. ... -
Pharmaceutical Industry Collaborations: Delivering Joint-Working Partnerships with the NHS
(British Academy of Management (BAM), 2018-09-04)The primary focus of this paper is to evaluate how pharmaceutical organisations in the United Kingdom deliver Joint Working initiatives in partnership with the healthcare service. Joint Working represents the most formalised ... -
Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
(2022-04-25)Introduction: The common technical document (CTD) format harmonised the requirements for the registration of medicines, which had traditionally differed from country to country, making it possible for countries to collaborate ... -
Pharmaceutical policy reforms to regulate drug prices in Asia Pacific Region: The case of Australia, China, India, Malaysia, New Zealand and South Korea
(2019-05)Medicine price directly affects affordability and access to medicines particularly in countries where a major portion of pharmaceutical spending is through out-of-pocket payment, such as in the Asia Pacific region. We have ... -
Pharmaceutical quality of anthelmintics sold in Kenya
(1998-04)Nine anthelmintic products purchased in pharmacies and from agricultural merchants in Kenya were tested for pharmaceutical quality. The concentration of active drug was compared with the claim on the label, and the variability ... -
Pharmacists' quality of learning in a diploma/MSc course in pharmacy practice
(1997-03)A rapid expansion of postgraduate courses in pharmacy practice has raised the issue of quality. An understanding of how pharmacists approach their learning is one factor that influences learning outcomes. It would, therefore, ... -
Pharmacodynamics and pharmacokinetics of carprofen in the horse.
(1994-05)The pharmacokinetics and pharmacodynamics of the nonsteroidal anti-inflammatory drug (NSAID) carprofen have been evaluated in 6 horses using a model of acute non-immune inflammation. Following intravenous administration ... -
Pharmacodynamics and pharmacokinetics of tolfenamicacid in ruminating calves: Evaluation in models of acute inflammation
(1998-05)Injections of mild irritants intradermally (carrageenan, zymosan and dextran) and intracaveally (carrageenan)in a tissue cage model of inflammation were used in studies of the pharmacodynamics and pharmacokinetics of ... -
The pharmacodynamics of ivermectin in sheep and cattle
(1988-09)The concentrations of ivermectin in the gastrointestinal tract of sheep and cattle were determined after subcutaneous administration of ivermectin. Ivermectin was not detected (limit of detection 1 ng/ml) in abomasal and ... -
Pharmacodynamics of tolfenamic acid in dogs : Evaluation of dose response relationships
(1994-03-03)Tolfenamic acid was administered to beagle dogs at 2, 4 and 8 mg/kg bodyweight i.m. and the concentration of drug in plasma and in inflamed (administered carrageenan) and non-inflamed subcutaneous tissue cage fluid was ... -
Pharmacodynamics, pharmacokinetics and faecal persistence of morantel in cattle and goats
(1993-03)Morantel could not be detected (<0.05 microgram/ml) in the plasma of cattle or goats following the oral administration of morantel tartrate at a dose rate of 10 mg/kg bodyweight. No morantel was detected in the milk of ... -
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes
(2020-09-01)Aims To study the pharmacodynamics and pharmacokinetics of selatogrel, a novel P2Y12 receptor antagonist for subcutaneous administration, in patients with chronic coronary syndromes (CCS). Methods In this double-blind, ... -
Pharmacoeconomic evaluation and its application in clinical guideline development
(2018-08-11)Pharmacoeconomic evaluation is an analysis technique that combines data on both costs and health outcomes to allow clinical decision makers to assess the cost effectiveness of pharmaceutical products and services. It is ... -
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology
(2024-01-08)The host immune system status remains an unresolved mystery among several malignancies. An immune-compromised state or smart immune-surveillance tactics orchestrated by cancer cells are the primary cause of cancer invasion ... -
Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica
(2002-09)The pharmacokinetics and pharmacodynamics of danofloxacin in calves with induced Mannheimia (Pasteurella) haemolytica pneumonia were evaluated. Calves received either saline as an intravenous (IV) bolus or danofloxacin ... -
Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats
(1997)Phenylbutazone was administered intravenously and orally to six goats as a single dose of 4.4 mg/kg and its disposition and bioavailability and the disposition of its active metabolite, oxyphenbutazone, in plasma were ...